Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients

Pediatric Nephrology

Volumn 31, Issue 4, 2016, Pages 661-669

  Hanudel, Mark R ^a   Wesseling Perry, Katherine ^a   Gales, Barbara ^a   Ramos, Georgina ^a   Campbell, Vicky ^a   Ethridge, Kristen ^a   Scotti, Mary ^a   Elashoff, David A ^a   Alejos, Juan ^a   Reemtsen, Brian ^a   Salusky, Isidro B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute kidney injury; Cardiac surgery; Chronic hypoxemia; Fibroblast growth factor 23; Pediatrics

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; OXYGEN; PARATHYROID HORMONE; PHOSPHATE; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR; PEPTIDE FRAGMENT;

ACUTE KIDNEY FAILURE; AORTA SUBVALVULAR STENOSIS; ARTICLE; ATRIOVENTRICULAR CANAL; CARBOXY TERMINAL SEQUENCE; CARDIOPULMONARY BYPASS; CHILD; CONTROLLED STUDY; CYANOTIC HEART DISEASE; EBSTEIN ANOMALY; FALLOT TETRALOGY; FEMALE; FONTAN PROCEDURE; GLENN SHUNT; GLOMERULUS FILTRATION RATE; HEART SURGERY; HEART VENTRICLE FUNCTION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOXEMIA; INFANT; KIDNEY FUNCTION; LUNG VEIN DRAINAGE ANOMALY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; MYOMECTOMY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY VALVE REPLACEMENT; SURGICAL PATIENT; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; BLOOD; CHRONIC DISEASE; HYPOXIA; PREDICTIVE VALUE; PRESCHOOL CHILD; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; BIOMARKERS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPOXIA; INFANT; MALE; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84959539535     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-015-3257-5     Document Type: Article

References (37)

1. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 4:561–568
2. Larsson T, Nisbeth U, Ljunggren O, Jüppner H, Jonsson KB (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 6:2272–2279
3. Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Jüppner H, Wolf M (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 7:2205–2215
4. Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F; MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P (2007) Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 9:2600–2608
5. Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Group (2011) Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305:2432–2439
6. Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 19:2545–2552
7. Christov M, Waikar SS, Pereira RC, Havasi A, Leaf DE, Goltzman D, Pajevic PD, Wolf M, Jüppner H (2013) Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney Int 4:776–785
8. Zhang M, Hsu R, Hsu CY, Kordesch K, Nicasio E, Cortez A, McAlpine I, Brady S, Zhuo H, Kangelaris KN, Stein J, Calfee CS, Liu KD (2011) FGF-23 and PTH levels in patients with acute kidney injury: a cross-sectional case series study. Ann Intensive Care 1:21
9. Leaf DE, Wolf M, Waikar SS, Chase H, Christov M, Cremers S, Stern L (2012) FGF- 23 levels in patients with AKI and risk of adverse outcomes. Clin J Am Soc Nephrol 8:1217–1223
10. Ali FN, Hassinger A, Price H, Langman CB (2013) Preoperative plasma FGF23 levels predict acute kidney injury in children: results of a pilot study. Pediatr Nephrol 6:959–962
11. Isakova T, Houston J, Santacruz L, Schiavenato E, Somarriba G, Harmon WG, Lipshultz SE, Miller TL, Rusconi PG (2013) Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure. Pediatr Nephrol 10:2035–2042
12. Hirao M, Hashimoto J, Yamasaki N, Ando W, Tsuboi H, Myoui A, Yoshikawa H (2007) Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes. J Bone Miner Metab 5:266–276
13. Clinkenbeard EL, Farrow EG, Summers LJ, Cass TA, Roberts JL, Bayt CA, Lahm T, Albrecht M, Allen MR, Peacock M, White KE (2014) Neonatal iron deficiency causes abnormal phosphorus metabolism by elevating FGF23 in normal and ADHR mice. J Bone Miner Res 2:361–369
14. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A (2008) Prevalence of congenital heart defects in metropolitan Atlanta, 1998–2005. J Pediatr 6:807–13
15. Li S, Krawczeski CD, Zappitelli M, Devarajan P, Thiessen-Philbrook H, Coca SG, Kim RW, Parikh CR; TRIBE-AKI Consortium (2011) Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: a prospective multicenter study. Crit Care Med 6:1493–1499
16. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Network AKI (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2:R31
17. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 3:571–590
18. Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2002) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 3:629–637
19. Fischer DC, Mischek A, Wolf S, Rahn A, Salweski B, Kundt G, Haffner D (2012) Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase. Ann Clin Biochem 6:546–553
20. Ardeshirpour L, Cole DE, Carpenter TO (2007) Evaluation of bone and mineral disorders. Pediatr Endocrinol Rev 5:584–598
21. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI (2002) Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 1:110–118
22. Sahai A, Mei C, Schrier RW, Tannen RL (1999) Mechanisms of chronic hypoxia- induced renal cell growth. Kidney Int 4:1277–1281
23. Eckardt KU, Bernhardt WM, Weidemann A, Warnecke C, Rosenberger C, Wiesener MS, Willam C (2005) Role of hypoxia in the pathogenesis of renal disease. Kidney Int S46–51
24. Nangaku M (2006) Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 1:17–25
25. Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M, Cohort CRI (2012) Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol 7:1155–1162
26. Neyra JA, Moe OW, Hu MC (2015) Fibroblast growth factor 23 and acute kidney injury. Pediatr Nephrol 30(11):1909–1918
27. Shimada T, Urakawa I, Isakova T, Yamazaki Y, Epstein M, Wesseling-Perry K, Wolf M, Salusky IB, Jüppner H (2010) Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. J Clin Endocrinol Metab 2:578–585
28. Smith ER, Cai MM, McMahon LP, Holt SG (2012) Biological variability of plasma intact and C-terminal FGF23 measurements. J Clin Endocrinol Metab 9:3357–3365
29. Tagliabracci VS, Engel JL, Wiley SE, Xiao J, Gonzalez DJ, Nidumanda Appaiah H, Koller A, Nizet V, White KE, Dixon JE (2014) Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis. Proc Natl Acad Sci U S A 15:5520–5525
30. Farrow EG, Yu X, Summers LJ, Davis SI, Fleet JC, Allen MR, Robling AG, Stayrook KR, Jideonwo V, Magers MJ, Garringer HJ, Vidal R, Chan RJ, Goodwin CB, Hui SL, Peacock M, White KE (2011) Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci U S A 46:E1146–1155
31. Imel EA, Peacock M, Gray AK, Padgett LR, Hui SL, Econs MJ (2011) Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. J Clin Endocrinol Metab 11:3541–3549
32. Wolf M, Koch TA, Bregman DB (2013) Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 8:1793–1803
33. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, Clopton P, Alberto J, Hlavin P, Maisel AS (2001) Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2:379–385
34. Strunk A, Bhalla V, Clopton P, Nowak RM, McCord J, Hollander JE, Duc P, Storrow AB, Abraham WT, Wu AH, Steg G, Perez A, Kazanegra R, Herrmann HC, Aumont MC, McCullough PA, Maisel A (2006) Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the breathing not properly multinational study. Am J Med 1:69.e1–11
35. Burlet A, Drukker A, Guignard JP (1999) Renal function in cyanotic congenital heart disease. Nephron 3:296–300
36. Agras PI, Derbent M, Ozcay F, Baskin E, Turkoglu S, Aldemir D, Tokel K, Saatci U (2005) Effect of congenital heart disease on renal function in childhood. Nephron Physiol 1:10–15
37. Zheng J, Yao Y, Han L, Xiao Y (2013) Renal function and injury in infants and young children with congenital heart disease. Pediatr Nephrol 1:99–104